REBLOZYL
Live / Registered — Registered (as of 01 Dec 2020)
What this means for you
Registered since 01 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88822744
- Registration number
- 6209351
- Mark type
- Design + words
- Filed
- 05 Mar 2020
- Published for opposition
- 15 Sept 2020
- Registered
- 01 Dec 2020
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease and cancer
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 01 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 15 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2020 — PUBLISHED FOR OPPOSITION
- 26 Aug 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Aug 2020 — ELECTRONIC RECORD REVIEW COMPLETE
- 07 Aug 2020 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 31 Jul 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jul 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED